NCT01566435View on ClinicalTrials.gov

Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 9, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2019

Conditions
Head and Neck Neoplasms
Interventions
DRUG

paclitaxel albumin-stabilized nanoparticle formulation

DRUG

Cisplatin

DRUG

Fluorouracil

RADIATION

Intensity modulated radiation therapy

DRUG

Cetuximab

PROCEDURE

Quality-of-life assessment

ACF baseline, IMRT baseline, Day 7, Week 12, months 6 and 12

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Washington University School of Medicine

OTHER